Novelion Therapeutics Tech Stack

Novelion Therapeutics uses 8 technology products and services including SiteCatalyst, Google Analytics, Google Font API, and more. Explore Novelion Therapeutics's tech stack below.

  • SiteCatalyst
    Analytics
  • Google Analytics
    Analytics
  • Google Font API
    Font Scripts
  • Backbone.js
    Javascript Frameworks
  • jQuery
    Javascript Libraries
  • Underscore.js
    Javascript Libraries
  • SWFObject
    Miscellaneous
  • Microsoft ASP.NET
    Web Frameworks

Media & News

Novelion Therapeutics's Email Address Formats

Novelion Therapeutics uses at least 4 format(s):
Novelion Therapeutics Email FormatsExamplePercentage
flast@qltinc.comJDoe@qltinc.com
98%
filast@qltinc.comJoDoe@qltinc.com
2%
first.last@novelion.comJohn.Doe@novelion.com
50%
first.last@novelion.comJohn.Doe@novelion.com
50%

Frequently Asked Questions

Where is Novelion Therapeutics's headquarters located?

Minus sign iconPlus sign icon
Novelion Therapeutics's main headquarters is located at Boston, US. The company has employees across 1 continents, including North America.

What is Novelion Therapeutics's phone number?

Minus sign iconPlus sign icon
You can contact Novelion Therapeutics's main corporate office by phone at +1-604-707-7001. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Novelion Therapeutics's stock symbol?

Minus sign iconPlus sign icon
Novelion Therapeutics is a publicly traded company; the company's stock symbol is NVLNF.

What is Novelion Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
Novelion Therapeutics's official website is novelion.com and has social profiles on LinkedIn.

What is Novelion Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
Novelion Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Novelion Therapeutics have currently?

Minus sign iconPlus sign icon
As of November 2021, Novelion Therapeutics has approximately 2 employees across 1 continents, including North America. Key team members include Chief Financial Officer: M. P.Director Of Quality Assurance: R. S. P.Analytics & Strategy Executive Director, Business: B. L.. Explore Novelion Therapeutics's employee directory with LeadIQ.

What industry does Novelion Therapeutics belong to?

Minus sign iconPlus sign icon
Novelion Therapeutics operates in the Biotechnology Research industry.

What technology does Novelion Therapeutics use?

Minus sign iconPlus sign icon
Novelion Therapeutics's tech stack includes SiteCatalystGoogle AnalyticsGoogle Font APIBackbone.jsjQueryUnderscore.jsSWFObjectMicrosoft ASP.NET.

What is Novelion Therapeutics's email format?

Minus sign iconPlus sign icon
Novelion Therapeutics's email format typically follows the pattern of flast@qltinc.com. Find more Novelion Therapeutics email formats with LeadIQ.

How much funding has Novelion Therapeutics raised to date?

Minus sign iconPlus sign icon
As of November 2021, Novelion Therapeutics has raised $50M in funding. .
Novelion Therapeutics

Novelion Therapeutics

Biotechnology ResearchBoston, United States201-500 Employees

Novelion Therapeutics is a biopharmaceutical company dedicated to developing new standards of care for individuals living with rare diseases. Novelion has a diversified commercial portfolio through its indirect subsidiary, Aegerion Pharmaceuticals, Inc. (Aegerion), which includes MYALEPT® and JUXTAPID®, and is also developing zuretinol acetate for the potential treatment of inherited retinal disease caused by underlying mutations in RPE65 or LRAT genes.  The company seeks to advance its portfolio of rare disease therapies by investing in science and clinical development.

Section iconCompany Overview

Headquarters
Boston, US
Phone number
+1-604-707-7001
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
NVLNF
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
201-500

Section iconFunding & Financials

  • $50M

    Novelion Therapeutics has raised a total of $50M of funding over 1 rounds. .

Section iconFunding & Financials

  • $50M

    Novelion Therapeutics has raised a total of $50M of funding over 1 rounds. .

© LeadIQ, Inc. All rights reserved.